World Fuel Services Corp. (INT) Financials Nov 20, 2014,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
World Fuel Services Corp. (INT) Financials Nov 20, 2014, 4:16 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for World Fuel Services Corp.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 11.3B 19.12B 34.61B 38.93B 41.54B
Cost of Goods Sold (COGS) incl. D&A 11.06B 18.86B 34.22B 38.52B 41.1B
COGS excluding D&A 11.04B 18.84B 34.18B 38.48B 41.05B
Depreciation & Amortization Expense 16.96M 19.11M 40.53M 36.71M 44.71M
Depreciation 8.66M 9.31M 15.53M 18.6M 22M
Amortization of Intangibles 8.3M 9.8M 25M 18.11M 22.71M
Gross Income 238.18M 265.33M 388.84M 416.53M 439.02M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 84.19M 98.82M 162.76M 179.06M 200.38M
Research & Development 0 0 0 0 0
Other SG&A 84.19M 98.82M 162.76M 179.06M 200.38M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 (16.81M) (30.51M) (17.33M) (21.72M)
EBIT after Unusual Expense 0 16.81M 30.51M 17.33M 21.72M
Non Operating Income/Expense (423,000) (1.05M) (2.56M) 3.89M 3.59M
Non-Operating Interest Income 1.22M 714,000 788,000 908,000 3.88M
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 4.88M 5.46M 16.61M 20.01M 21.17M
Gross Interest Expense 4.88M 5.46M 16.61M 20.01M 21.17M
Interest Capitalized 0 0 0 0 -
Pretax Income 149.91M 177.53M 238.2M 239.6M 246.67M
Income Tax 32.35M 31.03M 39M 38.24M 39.51M
Income Tax - Current Domestic (242,000) 13.6M 10.45M 7.8M 9.99M
Income Tax - Current Foreign 20.9M 22.37M 27.51M 24.65M 36.25M
Income Tax - Deferred Domestic 5.75M (5.7M) 8.41M 5.16M 4.24M
Income Tax - Deferred Foreign 2.17M (1.68M) (6.77M) 643,000 (10.98M)
Income Tax Credits (3.77M) (2.44M) 606,000 0 -
Equity in Affiliates 0 0 - 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 117.56M 146.5M 199.2M 201.35M 207.16M
Minority Interest Expense 424,000 (362,000) 5.17M 12.01M 4.09M
Net Income 117.14M 146.87M 194.03M 189.35M 203.08M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 117.14M 146.87M 194.03M 189.35M 203.08M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 117.14M 146.87M 194.03M 189.35M 203.08M
EPS (Basic) 1.99 2.36 2.74 2.66 2.85
Basic Shares Outstanding 59M 62.17M 70.69M 71.15M 71.22M
EPS (Diluted) 1.96 2.31 2.71 2.64 2.83
Diluted Shares Outstanding 59.9M 63.44M 71.51M 71.82M 71.8M
EBITDA 170.95M 185.62M 266.61M 274.18M 283.35M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 34

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 36

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 62

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 47

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 45

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Mixed Markets: Analyzing Germany's Stock Performance

Updated Category News Views 211

Markets in Germany Prepare for Fluctuations As trading wrapped up on Wednesday, the German stock market exhibited a mixed bag of results. While certain sectors, such as Food & Beverages, Media, and Financial Services, reported gains, others faced setbacks. The Consumer & Cyclical, Construction, and Pharmaceuticals & Healthcare sectors saw declines, reflecting the market's...

Continue Reading
Teradyne's Q3 Earnings: Strong Performance and Future Growth Potential

Updated Category News Views 176

Teradyne's Q3 Earnings Exceed Expectations Teradyne Incorporated (NASDAQ: TER), a prominent player in automated test equipment, has released its third-quarter results, building a narrative of success and optimism. The company reported impressive sales figures of $737 million, with non-GAAP earnings per share (EPS) reaching $0.90, bolstered by a solid gross margin of...

Continue Reading
So-Young Plans to Revise ADS Ratio for Improved Trading

Updated Category News Views 163

So-Young's Strategic Shift in ADS Ratio So-Young International Inc. (NASDAQ: SY), a leading aesthetic treatment platform, has recently announced plans to change the ratio of its American depositary shares (ADSs) to Class A ordinary shares. This strategic decision aims to refine its trading dynamics, enhancing value for its shareholders. Details of the ADS Ratio Change The...

Continue Reading
Understanding Recent Developments at GitLab: Investor Insights

Updated Category News Views 78

Contextual Overview of GitLab's Recent Investor Challenges In a rapidly evolving technological landscape, GitLab Inc. stands at a critical juncture as investors navigate its latest developments and challenges. Recent announcements regarding financial performance have sparked interest and concern among stakeholders. Understanding the implications of these changes is...

Continue Reading
Celebrating 15 Years of Transformative Care at Senderra Pharmacy

Updated Category News Views 273

15 Years of Innovation in Specialty Pharmacy Senderra Specialty Pharmacy has proudly reached a remarkable milestone—15 years of providing top-tier healthcare solutions in the specialty pharmacy sector. This anniversary embodies a journey marked by significant advancements and unwavering commitment to revolutionizing patient care. Transforming Patient Experiences Since...

Continue Reading